Nutex Health (NASDAQ:NUTX) Trading Up 5.1% – Here’s Why

Shares of Nutex Health Inc. (NASDAQ:NUTX) rose 5.1% during trading on Wednesday . The stock traded as high as $196.79 and last traded at $197.6470. 82,116 shares were traded during mid-day trading, a decline of 52% from the average session volume of 171,077 shares. The stock had previously closed at $188.10.

More Nutex Health News

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Zacks upgraded Nutex Health to “strong buy.” The upgrade reflects favorable momentum and fundamental factors, potentially attracting additional short-term buying interest. Here’s Why Trend Investors Would Love Betting on Nutex Health
• Positive Sentiment: Rising earnings estimates are signaling potential upside. Zacks said upward revisions support the stock’s recent strength, while analysts’ average price target implies approximately 47% additional upside, although price targets are not guarantees. Surging Earnings Estimates Signal Upside
• Positive Sentiment: NUTX passed a short-term trend-investing screen for stocks with strong recent price performance and sound fundamentals. Its latest reported quarter also included EPS of $9.38, well above the $4.95 consensus estimate, though revenue slightly missed expectations.
• Positive Sentiment: Nutex welcomed a Fifth Circuit ruling concerning the No Surprises Act. The decision rejected certain “ghost rate” methods used in calculating qualifying payment amounts, which could support the company’s position in out-of-network reimbursement disputes. Fifth Circuit Rejects Ghost Rates
• Neutral Sentiment: Analysts’ overall recommendation was reported as “moderate buy,” providing general support but not representing a unanimous bullish view. Nutex Health Analyst Recommendation
• Neutral Sentiment: A report showing zero short interest provides no meaningful short-squeeze signal; the accompanying percentage change was unavailable.
• Negative Sentiment: Nutex disclosed unauthorized activity in its information systems and said data was accessed or stolen. The incident could lead to investigation, remediation costs, legal exposure, notification expenses and reputational damage. The ultimate impact remains unclear while the company assesses the breach. Nutex Health Cyberattack Report

Wall Street Analysts Forecast Growth

NUTX has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Lake Street Capital reaffirmed a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. B. Riley Financial started coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective on the stock. Finally, Zacks Research raised Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Nutex Health has an average rating of “Buy” and a consensus target price of $300.00.

Nutex Health Stock Up 5.3%

The company has a market capitalization of $1.36 billion, a P/E ratio of 7.78 and a beta of 0.24. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The stock has a 50 day moving average price of $168.99 and a 200 day moving average price of $131.92.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, research analysts anticipate that Nutex Health Inc. will post 30.11 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutex Health

Several hedge funds have recently added to or reduced their stakes in NUTX. Hussman Strategic Advisors Inc. bought a new stake in shares of Nutex Health in the 4th quarter valued at $3,457,000. Quantinno Capital Management LP acquired a new stake in Nutex Health during the 1st quarter worth about $843,000. First Trust Advisors LP raised its position in shares of Nutex Health by 60.0% in the 1st quarter. First Trust Advisors LP now owns 18,335 shares of the company’s stock worth $1,743,000 after acquiring an additional 6,874 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of Nutex Health in the 1st quarter valued at about $3,084,000. Finally, SG Americas Securities LLC grew its stake in Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.